Parkinson's disease/Site map

From Wikiversity
Jump to navigation Jump to search

Each line in the hierarchical Site Map below is in two parts:

The link text as it usually appears in the text and
The link to the page or subpage with its full Wikiversity name.

The User Guide for this Wikiversity learning project is at PD_Wiki_User_Guide[edit | edit source]


The Science Behind Parkinson's - Portal:The_Science_Behind_Parkinson's[edit | edit source]

> Project Development - Portal:The_Science_Behind_Parkinson's/Project_Development
> The six purposes of Section 1 - Portal:The_Science_Behind_Parkinson's/Section 1/more

> Section 1: Progress and Prospects in Parkinson's Research - Progress_and_Prospects_in_Parkinson's_Research[edit | edit source]

> > - Magazine Section - PD_Magazine_Section[edit | edit source]
> Getting the ball rolling - PD_Magazine_Section/Getting_the_ball_rolling
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Researching Parkinson's - Researching_Parkinson's[edit | edit source]
> Modelling Parkinson's - Modelling_PD
> Animal Models - Modelling_PD/Animal_Models
> Rotenone Model - Modelling_PD/Rotenone PD Model
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Causes - PD_Causes[edit | edit source]
> Inheritance - PD_Inheritance
> SNCA - PD_Inheritance/SNCA
> LRRK2 - PD_Inheritance/LRRK2
> MAPT - PD_Inheritance/MAPT
> GBA - PD_Inheritance/GBA
> HLA - PD_Inheritance/HLA
> Trauma - Trauma as PD Cause
> Infection - Infection_as_PD_cause
> Melanoma - Infection_as_PD_cause/Melanoma
> Whooping cough - Infection_as_PD_cause/Whooping cough
> Helicobacter - Infection_as_PD_cause/Helicobacter_pylorii
> Deficiencies
> Blood - Deficiencies_as_PD_cause/Blood
> Glutathione - Deficiencies_as_PD_cause/Glutathione
> Melatonin - Deficiencies_as_PD_cause/Melatonin
> Norepinephrine - Deficiencies_as_PD_cause/Norepinephrine
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Zinc - Deficiencies_as_PD_cause/Zinc
> Toxins - Toxins_as_PD_cause
> Cadmium - Toxins_as_PD_cause/Cadmium
> Copper - Toxins_as_PD_cause/Copper
> Dieldrin - Toxins_as_PD_cause/Dieldrin
> Manganese - Toxins_as_PD_cause/Manganese
> Maneb - Toxins_as_PD_cause/Maneb
> Mercury - Toxins_as_PD_cause/Mercury
> MPTP - Toxins_as_PD_cause/MPTP
> n-Hexane - Toxins_as_PD_cause/n-Hexane
> Paraquat - Toxins_as_PD_cause/Paraquat
> Rotenone - Toxins_as_PD_cause/Rotenone
> Toluene - Toxins_as_PD_cause/Toluene
> Trichloroethylene - Toxins_as_PD_cause/Trichloroethylene
> Ziram - Toxins_as_PD_cause/Ziram
> > - Pathogenesis - Parkinson's_Pathogenesis[edit | edit source]
> Current Parkinson's Paradigm - Current_Parkinson's_Paradigm
> Working Hypothesis - Current_Parkinson's_Paradigm/Working_Hypothesis
> Emerging Hypotheses - Current_Parkinson's_Paradigm/Emerging_Hypotheses
> Oxidative Stress - Current_Parkinson's_Paradigm/Oxidative_Stress
> Role of alpha-synuclein - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> > - Therapy - PD_Therapy[edit | edit source]
> Transplantation - Transplantation_for_PD
> Symptomatic Relief - Symptomatic Relief_for_PD
> Bradykinesia - Symptomatic Relief_for_PD/Bradykinesia
> Dyskinesia - Symptomatic Relief_for_PD/Dyskinesia
> Festination - Symptomatic Relief_for_PD/Festination
> Freezing - Symptomatic Relief_for_PD/Akinesia
> Non-motor symptoms - Symptomatic Relief_for_PD/Non-Motor
> Tremor - Symptomatic Relief_for_PD/Tremor
> Exercise - Exercise_for_PD
> Effect on symptoms - Exercise_for_PD/Effect_on_Symptoms ::::> Neuroprotective effects - Exercise_for_PD/Neuroprotective_effects
> Neuroprotection - PD_Neuroprotection
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Caffeine - PD_Neuroprotection/Caffeine
> Celastrol - PD_Neuroprotection/Celastrol
> Co-enzyme Q10 - PD_Neuroprotection/Co-Enzyme Q10
> Creatine - PD_Neuroprotection/Creatine
> DHA - PD_Neuroprotection/DHA
> Exendin-4 (EX-4) - PD_Neuroprotection/Exendin-4 (EX-4)
> GDNF - PD_Neuroprotection/GDNF
> Glutathione (GSH) - PD_Neuroprotection/Glutathione (GSH)
> GM1 - PD_Neuroprotection/GM1
> Isradipine - PD_Neuroprotection/Isradipine
> Melatonin - PD_Neuroprotection/Melatonin
> Mirapex - PD_Neuroprotection/Mirapex
> Minocycline - PD_Neuroprotection/Minocycline
> Nicotine - PD_Neuroprotection/Nicotine
> NSAIDs - PD_Neuroprotection/NSAIDs
> Phenylbutyrate - PD_Neuroprotection/Phenylbutyrate
> Phytic Acid - PD_Neuroprotection/Phytic Acid
> Quinoxaline - PD_Neuroprotection/Quinoxaline
> Rasagiline - PD_Neuroprotection/Rasagiline
> Riboflavin - PD_Neuroprotection/Riboflavin
> Statins - PD_Neuroprotection/Statins
> Tolcapone - PD_Neuroprotection/Tolcapone
> Urate & Uric Acid - PD_Neuroprotection/Urate & Uric Acid
> Vitamin D - PD_Neuroprotection/Vitamin D
> Vitamin E - PD_Neuroprotection/Vitamin E
> From Lab to Clinic - PD_Research_to_clinic
> Clinical trials and the route to market - PD_Research_to_clinic/The route to market
> > - Monitoring Disease - Monitoring_Parkinson's_Disease[edit | edit source]
> Biomarkers - Biomarkers_for_PD
> Measurement of Disease Progression - Measurement_of_Parkinson's_Disease Progression
> > - Atypical parkinsonism - Atypical_parkinsonism[edit | edit source]
> MSA - Multiple_System_Atrophy
> PSP - Progressive_Supranuclear_Palsy
> DLB - Dementia_with_Lewy_Bodies
> ET - Essential Tremor
> CBD - Corticobasal_Degeneration_(CBD)

> Section 2: Introduction to Parkinson's Science - Introduction_to_Parkinson's_Science[edit | edit source]

> Site Map for Section 2 - Introduction_to_Parkinson's_Science/Site_Map
> > Initial Questions - Introduction_to_Parkinson's_Science/Q_Page_1[edit | edit source]
> > What causes the motor symptoms? - Introduction_to_Parkinson's_Science/Q_Page_2[edit | edit source]
> > Why is there not enough dopamine? - Introduction_to_Parkinson's_Science/Q_Page_3[edit | edit source]